| Authors: |
Tillett W; W. Tillett, MBChB, PhD, Department of Life Sciences, Centre for Therapeutic Innovation, Royal National Hospital for Rheumatic Diseases, Combe Park, Bath, UK; w.tillett@nhs.net., Coates LC; L.C. Coates, MBChB, PhD, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Center, Oxford, UK., Vis M; M. Vis, MD, PhD, Erasmus MC, Universitair Medisch Centrum Rotterdam, the Netherlands., Zimmermann M; M. Zimmermann, PhD, Johnson & Johnson, Zug, Switzerland., Lozenski K; K. Lozenski, PhD, Johnson & Johnson, Horsham, Pennsylvania, USA., Rampakakis E; E. Rampakakis, PhD, Department of Pediatrics, McGill University, Montreal, and Scientific Affairs, JSS Medical Research, Montreal, Quebec, Canada., Soriano ER; E.R. Soriano, MS, MD, Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Merola JF; J.F. Merola, MD, MMSc, Department of Dermatology, Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, Texas, USA., Sharaf M; M. Sharaf, Johnson & Johnson, Dubai, UAE., Nash P; P. Nash, MD, MBBS, School of Medicine, Griffith University, Nathan Brisbane, Queensland, Australia., Helliwell PS; P.S. Helliwell, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK. |
